Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Bioxytran Inc BIXT

Bioxytran, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the development, manufacture, and commercialization of therapeutic drugs designed to address hypoxia in humans. The Company's lead drug candidate, code named BXT-25, is an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer with an intended application, which includes... see more

OTCQB:BIXT - Post Discussion

Bioxytran Inc > $BIXT: Transforming Healthcare with Innovative Solutions
View:
Post by amritadanique on Oct 20, 2023 7:10am

$BIXT: Transforming Healthcare with Innovative Solutions

Bioxytran, Inc. ($BIXT) is a pioneering force in healthcare, focused on combating hypoxia with innovative pharmaceutical solutions. Their robust market capitalization, exceeding $24.5 million, and 144 million+ outstanding shares indicate the company's growth potential. With a strong 30-day average volume of 161,816, there's a growing interest in their transformative treatments. The previous closing price of $0.1699 underscores their promise to advance medical science. Bioxytran, Inc. is on a mission to improve patient outcomes and create a healthier world.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities